Also known as آسٹیوپوروسس مینجمنٹ
Gastroenterologist
M.B.B.S., M.D (Gastro), MACG(America)
Internal Medicine Specialist
M.B.B.S., F.C.P.S. (Medicine)
Internal Medicine Specialist
M.B.B.S, M.R.C.P (UK)
General Physician
MBBS, FCPS (Endocrinology), FCPS (Medicine), SCE Endocrinology (London)
General Physician
MBBS, FCPS (Endocrinology), FCPS (Medicine), SCE Endocrinology (London)
Diabetologist
M.D (St'Lucia), Diplomate Diabetes
Diabetologist
M.B.B.S., M.R.C.P (UK), MRCP SCE Endocrinology and diabetes , PG Endocrinology , Certificate for obesity management
Diabetologist
M.B.B.S., M.R.C.P (UK), MRCP SCE Endocrinology and diabetes , PG Endocrinology , Certificate for obesity management
Internal Medicine Specialist
M.B.B.S., F.C.P.S.
Diabetologist
M.B.B.S., DIP DAB
Internal Medicine Specialist
M.B.B.S., F.C.P.S (Medicine), ICMT
Internal Medicine Specialist
M.B.B.S, F.C.P.S (Medicine)
Bisphosphonates are used as first-line pharmacologictreatment for osteoporosis. In patients who cannot tolerate or whose symptoms do not improve with bisphosphonate therapy, teriparatide (Forteo) and denosumab (Prolia) are effective alternative medications to prevent osteoporotic fractures